A company still losing money with shrinking sales, with high risk. Institutions are trimming.
Facts from SEC filings, not a recommendation.
Last 12 months: $28.2M, down 2.5% from the 12 months before.
Price chart by TradingView.
From annual reports filed with the SEC. Gross margin doesn't apply to banks and insurers, so it isn't scored. Not in this company's SEC data, so not scored: return on equity 15%+, debt under half of equity, profitable every year, share count not growing. A checklist is a starting point for research, not a verdict.
50 is neutral. Buying by more insiders, top executives and bigger stakes raises it. Selling lowers it; pre-planned sales count less.
SEC filings of any kind. 50 means a normal week.
Institutions cut 4.5% from their holdings. 28 bought, 36 sold.
| Insider | Trade | Shares | Avg price | Value | Owns after | Date |
|---|---|---|---|---|---|---|
Matt McmanusChief Operating Officer | Sell | 2K | $0.51 | $1K | 381K | Oct 22Filing ↗ |
| ||||||
Wolfe RepassChief Financial Officer | Sell | 1K | $0.53 | $652 | 740K | Oct 2Filing ↗ |
| ||||||
William Brian Poppic ReevesChief Executive Officer | Sell | 5K | $0.53 | $3K | 5M | Oct 2Filing ↗ |
| ||||||
Thomas J DickmanChief Technology Officer | Sell | 6 | $0.53 | $3 | 542K | Oct 2Filing ↗ |
| ||||||
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.
2,347 shares at $0.51 · $1K
6 shares at $0.53 · $3
5,304 shares at $0.53 · $3K
1,231 shares at $0.53 · $652
20,000 shares at $0.55 avg ($0.54 to $0.56) · $11K
Source: SEC EDGAR filings. For informational purposes. Not investment advice.
Report a problem with this page